IP Verse

Pharmaceutical Compositions For The Treatment Of Cystic Fibrosis Transmembrane Conductance Regulator Mediated Diseases - EP3925607

PATENT ANALYSIS

Patent Details

Grant Date
Jun 28, 2023
Company
VERTEX PHARMACEUTICALS INCORPORATED
Oppositions

GENERICS [UK] LIMITED

More patents of Vertex Pharmaceuticals Incorporated

EP2464337

EP2914248

EP3925607

Want to monitor this patent?

Feel free to send us a message here and we will get back to you